Literature DB >> 26823725

Osteopontin facilitates invasion in human trophoblastic cells via promoting matrix metalloproteinase-9 in vitro.

Lian-Zhi Wu1, Xue-Li Liu2, Qing-Zhen Xie1.   

Abstract

Successful implantation of embryo and placentation depend on proper trophoblast proliferation and differentiated into specialized invasive trophoblast. However, little is known about the regulatory factors and mechanisms in trophoblast proliferation and differentiation. Osteopontin (OPN) is a member of the small integrin-binding ligand N-linked glycoprotein family and participates in cell adhesion and invasion. It has been identified that OPN is highly expressed in invasive trophoblasts in human placenta. In this study, we demonstrated that OPN is constitutively expressed in highly invasive phenotype of human choriocarcinoma cell lines of JAR and JEG-3 cells, and OPN could promote trophoblast proliferation and invasion, partly through promoting MMP-9 secretion. Inhibition of OPN will compromise the abilities of proliferation and invasion in JAR and JEG-3 cell lines. Our data showed that the expression of OPN in trophoblast may participate in placentation, OPN expression defects may be involved in gestational trophoblastic diseases.

Entities:  

Keywords:  Osteopontin; adhesion; invasion; trophoblast

Mesh:

Substances:

Year:  2015        PMID: 26823725      PMCID: PMC4713511     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

1.  Osteopontin expression in gestational trophoblastic diseases: correlation with expression of the adhesion molecule, CEACAM1.

Authors:  Juliane Briese; Marine Oberndörfer; Heinrich M Schulte; Thomas Löning; A M Bamberger
Journal:  Int J Gynecol Pathol       Date:  2005-07       Impact factor: 2.762

2.  Osteopontin is colocalized with the adhesion molecule CEACAM1 in the extravillous trophoblast of the human placenta and enhances invasion of CEACAM1-expressing placental cells.

Authors:  Juliane Briese; Marine Oberndörfer; Christine Pätschenik; Heinrich M Schulte; Antonis Makrigiannakis; Thomas Löning; Ana-Maria Bamberger
Journal:  J Clin Endocrinol Metab       Date:  2005-06-14       Impact factor: 5.958

3.  Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos.

Authors:  E J Whiteside; M M Jackson; A C Herington; D R Edwards; M B Harvey
Journal:  Biol Reprod       Date:  2001-05       Impact factor: 4.285

4.  Expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinases during mouse embryonic development.

Authors:  Li Chen; Masaaki Nakai; Robert J Belton; Romana A Nowak
Journal:  Reproduction       Date:  2007-02       Impact factor: 3.906

5.  Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice.

Authors:  Yasushi Hirota; Takiko Daikoku; Susanne Tranguch; Huirong Xie; Heather B Bradshaw; Sudhansu K Dey
Journal:  J Clin Invest       Date:  2010-03       Impact factor: 14.808

Review 6.  Osteopontin: roles in implantation and placentation.

Authors:  Greg A Johnson; Robert C Burghardt; Fuller W Bazer; Thomas E Spencer
Journal:  Biol Reprod       Date:  2003-07-30       Impact factor: 4.285

7.  Osteopontin is down-regulated in hydatidiform mole.

Authors:  Jozsef Batorfi; Vilmos Fulop; Jae-Hoon Kim; David R Genest; Jozsef Doszpod; Samuel C Mok; Ross S Berkowitz
Journal:  Gynecol Oncol       Date:  2003-04       Impact factor: 5.482

8.  Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells.

Authors:  Ying-Ju Chen; Ying-Ying Wei; Hsien-Te Chen; Yi-Chin Fong; Chin-Jung Hsu; Chun-Hao Tsai; Horng-Chaung Hsu; Shing-Hwa Liu; Chih-Hsin Tang
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 9.  Extracellular matrix proteases - cytokine regulation role in cancer and pregnancy.

Authors:  Su-Cheng Huang; Bor-Ching Sheu; Wen-Chun Chang; Chieh-Yang Cheng; Peng-Hui Wang; Shiming Lin
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

Authors:  Bhavik Desai; Michael J Rogers; Meenakshi A Chellaiah
Journal:  Mol Cancer       Date:  2007-03-07       Impact factor: 27.401

View more
  5 in total

1.  Osteopontin - a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease.

Authors:  Bogdan-Ioan Coculescu; Gheorghe Manole; Gabi Valeriu Dincă; Elena Claudia Coculescu; Cristina Berteanu; Cristina Mariana Stocheci
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

2.  Osteopontin Promotes Trophoblast Invasion in the Smooth Muscle Cell-Endothelial Co-Culture At Least Via Targeting Integrin αvβ3.

Authors:  Ru Ke; Liting Zheng; Falan Zhao; Junxia Xia
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

3.  Increased expression of osteopontin in subchondral bone promotes bone turnover and remodeling, and accelerates the progression of OA in a mouse model.

Authors:  Chuangxin Lin; Zhong Chen; Dong Guo; Laixi Zhou; Sipeng Lin; Changchuan Li; Shixun Li; Xinjia Wang; Bendan Lin; Yue Ding
Journal:  Aging (Albany NY)       Date:  2022-01-04       Impact factor: 5.682

4.  Effect of Placenta-Derived Mesenchymal Stromal Cells Conditioned Media on an LPS-Induced Mouse Model of Preeclampsia.

Authors:  Anna Maria Nuzzo; Laura Moretti; Paolo Mele; Tullia Todros; Carola Eva; Alessandro Rolfo
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

5.  IL‑33 restricts invasion and adhesion of trophoblast cell line JEG3 by downregulation of integrin α4β1 and CD62L.

Authors:  Xiao-Hui Wang; Wei Liu; Deng-Xuan Fan; Wen-Ting Hu; Ming-Qing Li; Xiao-Yong Zhu; Li-Ping Jin
Journal:  Mol Med Rep       Date:  2017-07-26       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.